Happiness Biotech Group Current Ratio 2019-2021 | HAPP

Happiness Biotech Group current ratio from 2019 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Happiness Biotech Group Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-03-31 $0.10B $0.02B 6.30
2020-09-30 $0.08B $0.01B 12.82
2020-03-31 $0.07B $0.01B 12.71
2019-09-30 $0.06B $0.01B 11.72
2019-03-31 $0.06B $0.01B 11.51
2018-03-31 $0.04B $0.01B 4.95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.031B $0.071B
Happiness Biotech Group Limited is a nutraceutical and dietary supplements producer. It is focused on the research, development, manufacturing and marketing of products made from Chinese herbal extracts and other ingredients. Happiness Biotech Group Limited is based in NANPING, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86